Table 3 Indications for lymphadenectomy based on japanese, european, american and french recommendations
From: Optimal lymph node dissection for gastric cancer: a narrative review
Lymph Node Dissection | JGCA 2021 [20] | ESMO 2022 [18] | NCCN 2019 [19] | TNCD 2022 [22] |
|---|---|---|---|---|
D1 recommendation | Grade 2 A | |||
indications | T1aN0 T1bN0, differentiated, < 1.5 cm | Not recommended | Localized resectable cancer | T1aN0 High operative risk patients Prophylactic gastrectomy for CDH1 mutation |
D1+ recommendation | ||||
indications | T1N0 not mentioned above | T1N0 | Not mentioned | |
D2 recommendation | Grade 2B | Grade 2 A | ||
indications | T2-T4, T1N+ | T2-T4 ou N+ by experienced surgeon | T1b-T4 by experienced surgeon | T1b-T4 ou N+ |
D2+ recommendation | ||||
indications | Metastasis to N°10, 14v, 13, 16 lymph node | Not mentioned | Not mentioned | Not mentioned |
Splenectomy recommendation | ||||
indications | Greater curvature tumor (expert consensus) | Not mentioned | Not recommended | T3-T4 tumor of the greater curvature (expert consensus) |